Teamwork Makes the Dream Work
Part of paid clinical trials in Loma Linda, California.
- Sponsor
- Loma Linda University
- Study ID
- NCT05866523
- Status
- Recruiting
Conditions
- HIV Infections
- Inpatient Facility Diagnoses
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Team Based Inpatient ARTAS — BEHAVIORALInfectious Disease Team will provide inpatient consultation. Social Work Team will provide 1 session of case management inpatient and up to 5 case management sessions within 90 days post discharge or until the client is linked to medical care as evidenced by visit with HIV specialist within 90 days post discharge.
- Standard of Care — BEHAVIORALSubject admitted and seen by routine inpatient medical service.
Study Details
Exploring the effect of team-based ARTAS intervention in an inpatient setting on HIV linkage to care and hospital readmission rates.
Key Dates
- Start date
- Oct 16, 2023
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- OTHER
Arms
- Active Comparator: Standard of Care Historic ControlControl group will get treatment as usual, which consists of medical care by primary admitting service
- Active Comparator: Team based inpatient ARTASEligible patients after the study consent process will receive Antiretroviral Treatment Access Study (ARTAS) intervention by social-worker and a medical consultation by an infectious disease physician
Primary Outcome Measure
Rate of linkage to HIV care post discharge [ Time Frame: Up to 90 days post-study enrollment hospitalization discharge ]
Central Contacts
- Jennifer Veltman, MD909 558 4000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Loma Linda University Medical Center | Loma Linda | California | 92354 |
Find similar trials in Loma Linda, CA
By condition
By specialty
By research site
Related Studies
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruiting · University of California, San Francisco · San Francisco, California
- Imaging Immune Activation in HIV by PET-MRPHASE2 · Recruiting · CellSight Technologies, Inc. · San Francisco, California
- CAR-T Cells for HIV InfectionPHASE1/PHASE2 · Recruiting · Steven Deeks · Sacramento, California
- Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV PreventionRecruiting · Public Health Foundation Enterprises, Inc. · San Francisco, California